Cargando…
How are HCV-infected patients being identified in Brazil: a multicenter study
BACKGROUND: Hepatitis C is an important health problem. In Brazil, 1–2 million people are infected. Despite this expressive number, and the availability of very successful treatment, many patients remained undiagnosed mainly because of the asymptomatic nature of the infection. OBJECTIVES: To describ...
Autores principales: | Portari-Filho, Luiz H., Álvares-da-Silva, Mario R., Gonzalez, Aline, Ferreira, Adalgisa P., Villela-Nogueira, Cristiane A., Mendes-Correa, Maria C., Lima, José M., Lopes, Edmundo P., Brandão, Carlos E., Ivantes, Cláudia, Lyra, André, Lindenberg, Andreia, Ferraz, Maria L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427979/ https://www.ncbi.nlm.nih.gov/pubmed/30849332 http://dx.doi.org/10.1016/j.bjid.2019.01.006 |
Ejemplares similares
-
Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study
por: Callefi, Luciana Azevedo, et al.
Publicado: (2017) -
Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study
por: Pereira, Gustavo H., et al.
Publicado: (2022) -
Results of interferon-free treatment for HCV-infected patients with decompensated cirrhosis from a Brazilian real-life cohort
por: Victor, Lívia, et al.
Publicado: (2022) -
Peginterferon plus ribavirin and sustained virological response rate in HCV-related advanced fibrosis: a real life study
por: Silva, Giovanni Faria, et al.
Publicado: (2013) -
Impact of vitamin D receptor and binding protein gene polymorphisms in clinical and laboratory data of HCV patients: Cross sectional study
por: Scalioni, Letícia de Paula, et al.
Publicado: (2018)